Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties

Journal of the Neurological Sciences

Volumn 320, Issue 1-2, 2012, Pages 45-51

  Liu, Shuo ^a   Yu, Chuanhui ^a   Yang, Fan ^a   Paganini Hill, Annlia ^a   Fisher, Mark J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell culture; Endothelial; Histamine; Microcirculation; Phosphodiesterase

Indexed keywords

ALBUMIN; CILOSTAZOL; CLAUDIN 5; DEXTRAN; DIPYRIDAMOLE; F ACTIN; HISTAMINE; KT 5720; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM;

ARTICLE; BLOOD BRAIN BARRIER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC RESISTANCE; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; MEMBRANE PERMEABILITY; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ACTINS; BRAIN; CAPILLARY PERMEABILITY; CARBAZOLES; CELLS, CULTURED; CLAUDIN-5; DIPYRIDAMOLE; DRUG INTERACTIONS; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; HISTAMINE; HUMANS; ISOQUINOLINES; PHOSPHODIESTERASE INHIBITORS; PROTEIN KINASE INHIBITORS; PYRROLES; ROLIPRAM; SULFONAMIDES; TETRAZOLES;

EID: 84864606742     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.06.005     Document Type: Article

References (73)

1. A.J. Farrall, and J.M. Wardlaw Blood-brain barrier: ageing and microvascular disease - systematic review and meta-analysis Neurobiol Aging 30 3 2009 337 352
2. G.J. del Zoppo The neurovascular unit in the setting of stroke J Intern Med 267 2 2010 156 171
3. N. Zeevi, J. Pachter, L.D. McCullough, L. Wolfson, and G.A. Kuchel The blood-brain barrier: geriatric relevance of a critical brain-body interface J Am Geriatr Soc 58 9 2010 1749 1757
4. M. Fisher The challenge of mixed cerebrovascular disease Ann N Y Acad Sci 1207 2010 18 22
5. M. Fisher, S. French, P. Ji, and R.C. Kim Cerebral microbleeds in the elderly: a pathological analysis Stroke 41 12 2010 2782 2785
6. K.M. Cullen, Z. Kocsi, and J. Stone Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex J Cereb Blood Flow Metab 25 12 2005 1656 1667
7. V.G. Young, G.M. Halliday, and J.J. Kril Neuropathologic correlates of white matter hyperintensities Neurology 71 11 2008 804 811
8. M.W. Vernooij, M.D. Haag, A. van der Lugt, A. Hofman, G.P. Krestin, and B.H. Stricker Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study Arch Neurol 66 6 2009 714 720
9. M. Matsumoto Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study Atheroscler Suppl 6 4 2005 33 40
10. J.H. Lee, S.Y. Park, H.K. Shin, C.D. Kim, W.S. Lee, and K.W. Hong Protective effects of cilostazol against transient focal cerebral ischemia and chronic cerebral hypoperfusion injury CNS Neurosci Ther 14 2 2008 143 152
11. Y. Shinohara, Y. Katayama, S. Uchiyama, T. Yamaguchi, S. Handa, and K. Matsuoka Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial Lancet Neurol 9 10 2010 959 968
12. P.E. Thompson, V. Manganiello, and E. Degerman Re-discovering PDE3 inhibitors - new opportunities for a long neglected target Curr Top Med Chem 7 4 2007 421 436
13. C. Lugnier Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents Pharmacol Ther 109 3 2006 366 398
14. B.E. Blackman, K. Horner, J. Heidmann, D. Wang, W. Richter, and T.C. Rich PDE4D and PDE4B function in distinct subcellular compartments in mouse embryonic fibroblasts J Biol Chem 286 2011 12590 12601
15. M. Conti, and J. Beavo Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling Annu Rev Biochem 76 2007 481 511
16. H.C. Diener Dipyridamole trials in stroke prevention Neurology 51 3 Suppl 3 1998 S17 S19
17. C.D. d'Esterre, and T.Y. Lee Effect of dipyridamole during acute stroke: exploring antithrombosis and neuroprotective benefits Ann N Y Acad Sci 1207 2010 71 75
18. L. Zhang, Z. Zhang, R.L. Zhang, Y. Cui, M.C. LaPointe, and B. Silver Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke Brain Res 1118 1 2006 192 198
19. Y.-Y. Huang, K.C. Martin, and E.R. Kandel Both protein kinase A and mitogen-activated protein kinase are required in the amygdala for the macromolecular synthesis-dependent late phase of long-term potentiation J Neurosci 20 17 2000 6317 6325
20. Z. Wu, F.M. Hofman, and B.V. Zlokovic A simple method for isolation and characterization of mouse brain microvascular endothelial cells J Neurosci Methods 130 1 2003 53 63
21. K.M. Hoque, O.M. Woodward, D.B. van Rossum, N.C. Zachos, L. Chen, and G.P. Leung Epac1 mediates protein kinase A-independent mechanism of forskolin-activated intestinal chloride secretion J Gen Physiol 135 1 2010 43 58
22. S. Fukuhara, A. Sakurai, H. Sano, A. Yamagishi, S. Somekawa, and N. Takakura Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway Mol Cell Biol 25 1 2005 136 146
23. H. Torii, H. Kubota, H. Ishihara, and M. Suzuki Cilostazol inhibits the redistribution of the actin cytoskeleton and junctional proteins on the blood-brain barrier under hypoxia/reoxygenation Pharmacol Res 55 2 2007 104 110
24. W. Shen, J. Hao, Z. Feng, C. Tian, W. Chen, and L. Packer Lipoamide or lipoic acid stimulates mitochondrial biogenesis in 3T3-L1 adipocytes via the endothelial NO synthase-cGMP-protein kinase G signalling pathway Br J Pharmacol 162 5 2011 1213 1224
25. B. Korkmaz, K. Buharalioglu, S. Sahan-Firat, T,. Cuez, A. Tuncay Demiryurek, and B. Tunctan Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway associated with peroxynitrite formation contributes to hypotension and vascular hyporeactivity in endotoxemic rats Nitric Oxide 24 3 2011 160 172
26. M.J. Vliem, B. Ponsioen, F. Schwede, W.J. Pannekoek, J. Riedl, and M.R. Kooistra 8-pCPT-2′-O-Me-cAMP-AM: an improved Epac-selective cAMP analogue Chembiochem 9 13 2008 2052 2054
27. N.M. Pastor-Soler, K.R. Hallows, C. Smolak, F. Gong, D. Brown, and S. Breton Alkaline pH- and cAMP-induced V-ATPase membrane accumulation is mediated by protein kinase A in epididymal clear cells Am J Physiol Cell Physiol 294 2 2008 C488 C494
28. E.P. Eddy, B.E. Maleef, T.K. Hart, and P.L. Smith In vitro models to predict blood-brain barrier permeability Adv Drug Deliv Rev 23 1-3 1997 185 198
29. M.A. Deli, C.S. Abraham, Y. Kataoka, and M. Niwa Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology Cell Mol Neurobiol 25 1 2005 59 127
30. J. Waschke, D. Drenckhahn, R.H. Adamson, H. Barth, and F.E. Curry cAMP protects endothelial barrier functions by preventing Rac-1 inhibition Am J Physiol Heart Circ Physiol 287 6 2004 H2427 H2433
31. Y. Baumer, D. Drenckhahn, and J. Waschke cAMP induced Rac 1-mediated cytoskeletal reorganization in microvascular endothelium Histochem Cell Biol 129 6 2008 765 778
32. N.S. Umapathy, Z. Fan, E.A. Zemskov, I.B. Alieva, S.M. Black, and A.D. Verin Molecular mechanisms involved in adenosine-induced endothelial cell barrier enhancement Vascul Pharmacol 52 2010 199 206
33. C.J. Schankin, L.S. Kruse, V.M. Reinisch, S. Jungmann, J.C. Kristensen, and S. Grau Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5 Headache 50 3 2010 431 441
34. T. Sudo, K. Tachibana, K. Toga, S. Tochizawa, Y. Inoue, and Y. Kimura Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity Biochem Pharmacol 59 4 2000 347 356
35. Y. Liu, Y. Shakur, M. Yoshitake, and J. Ji Kambayashi Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake Cardiovasc Drug Rev 19 4 2001 369 386
36. S. Birk, L. Edvinsson, J. Olesen, and C. Kruuse Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries Eur J Pharmacol 489 1-2 2004 93 100
37. T. Sudo, H. Ito, and Y. Kimura Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets Platelets 14 6 2003 381 390
38. H.H. Kim, and J.K. Liao Translational therapeutics of dipyridamole Arterioscler Thromb Vasc Biol 28 3 2008 s39 s42
39. L.L. Rubin, D.E. Hall, S. Porter, K. Barbu, C. Cannon, and H.C. Horner A cell culture model of the blood-brain barrier J Cell Biol 115 6 1991 1725 1735
40. A. Toth, S. Veszelka, S. Nakagawa, M. Niwa, and M.A. Deli Patented in vitro blood-brain barrier models in CNS drug discovery Recent Pat CNS Drug Discov 6 2 2011 107 118
41. T.J. Raub Signal transduction and glial cell modulation of cultured brain microvessel endothelial cell tight junctions Am J Physiol 271 2 Pt 1 1996 C495 C503
42. D. Zenker, D. Begley, H. Bratzke, H. Rubsamen-Waigmann, and H. von Briesen Human blood-derived macrophages enhance barrier function of cultured primary bovine and human brain capillary endothelial cells J Physiol 551 Pt 3 2003 1023 1032
43. M. Ishiguro, Y. Suzuki, K. Mishiro, M. Kakino, K. Tsuruma, and M. Shimazawa Blockade of phosphodiesterase-III protects against oxygen-glucose deprivation in endothelial cells by upregulation of VE-cadherin Curr Neurovasc Res 8 2 2011 86 94
44. M. Ishiguro, K. Mishiro, Y. Fujiwara, H. Chen, H. Izuta, and K. Tsuruma Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA PLoS One 5 12 2010 e15178
45. A.S. Easton, and K. Dorovini-Zis The kinetics, function, and regulation of P-selectin expressed by human brain microvessel endothelial cells in primary culture Microvasc Res 62 3 2001 335 345
46. V.A. Folcik, T. Smith, S. O'Bryant, J.A. Kawczak, B. Zhu, and H. Sakurai Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors J Neuroimmunol 97 1-2 1999 119 128
47. S. Guo, M. Stins, M. Ning, and E.H. Lo Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells Cerebrovasc Dis 30 3 2010 290 296
48. J.B. Mackic, M. Stins, S. Jovanovic, K.S. Kim, R.T. Bartus, and B.V. Zlokovic Cereport (RMP-7) increases the permeability of human brain microvascular endothelial cell monolayers Pharm Res 16 9 1999 1360 1365
49. F. Yang, S. Liu, S.J. Wang, C. Yu, A. Paganini-Hill, and M.J. Fisher Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells Cell Physiol Biochem 28 4 2011 631 638
50. D.H. Lee, H.R. Lee, H.K. Shin, S.Y. Park, K.W. Hong, and E.K. Kim Cilostazol enhances integrin-dependent homing of progenitor cells by activation of cAMP-dependent protein kinase in synergy with Epac1 J Neurosci Res 89 2011 650 660
51. F. Yang, S. Liu, C. Yu, S.J. Wang, A. Paganini-Hill, and M.J. Fisher PDE4 regulates tissue plasminogen activator expression of human brain microvascular endothelial cells Thromb Res 129 2012 750 753
52. M. Conti Phosphodiesterases and cyclic nucleotide signaling in endocrine cells Mol Endocrinol 14 9 2000 1317 1327
53. H. Penmatsa, W. Zhang, S. Yarlagadda, C. Li, V.G. Conoley, and J. Yue Compartmentalized cyclic adenosine 3′,5′-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains Mol Biol Cell 21 6 2010 1097 1110
54. D.M. Cooper Compartmentalization of adenylate cyclase and cAMP signalling Biochem Soc Trans 33 Pt 6 2005 1319 1322
55. F. Liu, A.D. Verin, T. Borbiev, and J.G. Garcia Role of cAMP-dependent protein kinase A activity in endothelial cell cytoskeleton rearrangement Am J Physiol Lung Cell Mol Physiol 280 6 2001 L1309 L1317
56. N. Prasain, and T. Stevens The actin cytoskeleton in endothelial cell phenotypes Microvasc Res 77 1 2009 53 63
57. N.J. Abbott, L. Ronnback, and E. Hansson Astrocyte-endothelial interactions at the blood-brain barrier Nat Rev Neurosci 7 1 2006 41 53
58. T. Ishizaki, H. Chiba, T. Kojima, M. Fujibe, T. Soma, and H. Miyajima Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways Exp Cell Res 290 2 2003 275 288
59. N. Perrière, S. Yousif, S. Cazaubon, N. Chaverot, F. Bourasset, and S. Cisternino A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters Brain Res 1150 2007 1 13
60. 2 + signaling in the regulation of endothelial permeability Vascul Pharmacol 39 4-5 2002 173 185
61. B.L. Jones, and G.L. Kearns Histamine: new thoughts about a familiar mediator Clin Pharmacol Ther 89 2011 189 197
62. N.J. Abbott Inflammatory mediators and modulation of blood-brain barrier permeability Cell Mol Neurobiol 20 2 2000 131 147
63. G.P. van Nieuw Amerongen, R. Draijer, M.A. Vermeer, and V.W. van Hinsbergh Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA Circ Res 83 11 1998 1115 1123
64. S.P. Srinivas, M. Satpathy, Y. Guo, and V. Anandan Histamine-induced phosphorylation of the regulatory light chain of myosin II disrupts the barrier integrity of corneal endothelial cells Invest Ophthalmol Vis Sci 47 9 2006 4011 4018
65. K.F. Buckland, T.J. Williams, and D.M. Conroy Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor Br J Pharmacol 140 6 2003 1117 1127
66. Y. Guo, C. Ramachandran, M. Satpathy, and S.P. Srinivas Histamine-induced myosin light chain phosphorylation breaks down the barrier integrity of cultured corneal epithelial cells Pharm Res 24 10 2007 1824 1833
67. 2 +]i and force in middle cerebral artery of the rabbit Br J Pharmacol 123 5 1998 869 878
68. H. Wolburg, J. Neuhaus, U. Kniesel, B. Krauss, E. Schmid, and M. Ocalan Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes J Cell Sci 107 5 1994 1347 1357
69. H. Ota, M. Eto, M.R. Kano, S. Ogawa, K. Iijima, and M. Akishita Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells Arterioscler Thromb Vasc Biol 28 9 2008 1634 1639
70. K. Schror The pharmacology of cilostazol Diabetes Obes Metab 4 Suppl. 2 2002 S14 S19
71. Hashimoto Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A-and phosphatidylinositol 3-kinase/Akt-dependent mechanism Atherosclerosis 189 2 2006 350
72. T. Morikawa, K. Hattori, M. Kajimura, and M. Suematsu The effects of cilostazol on tissue oxygenation upon an ischemic-reperfusion injury in the mouse cerebrum Adv Exp Med Biol 662 2010 89 94
73. N. Schlegel, Y. Baumer, D. Drenckhahn, and J. Waschke Lipopolysaccharide-induced endothelial barrier breakdown is cyclic adenosine monophosphate dependent in vivo and in vitro Crit Care Med 37 5 2009 1735 1743